Hedge fund manager and science philanthropist Jeffrey Epstein is helping to fund research aimed combat colon cancer.
The undisclosed funding from Epstein, a former Bear Stearns trader and founder of investment firm The Financial Trust Company, will go toward a colon cancer research campaign led by Martin Nowak of Harvard University’s Program for Evolutionary Dynamics. Nowak and his team will set out to figure out why 28 colon cancer patients at John Hopkins University were showing resistance to inhibitor drugs.
eVestment reported earlier this month that the Program for Evolutionary Dynamics, which was founded by Epstein, will work in conjunction with the Elton John AIDS Foundation to fight HIV resistance. That partnership supports the new approach of tailoring treatment on an individual basis based on genotype, viral load and other factors, compared to the decade-long method of applying a slew of inhibitors and other drugs to suppress the HIV virus.
An active member in philanthropy, Epstein also established the Jeffrey Epstein VI Foundation in 2000 to support cutting edge science research across the globe.